Abu Dhabi Stem Cells Center — Clinics

Address & contact

https://adscc.ae/

Specialties

hematopoietic stem cell transplantation CAR-T cell therapy CRISPR-based gene therapy cellular therapy stem cell therapy CAR-T cell manufacturing clinical trials bone marrow transplantation gene therapy

Reports that name this provider

Stem Cell Legality in United Arab Emirates: First facility in UAE and one of only two in Middle East with FACT-JACIE accreditation for cellular therapy (May 2024). JCI Gold Seal of Approval (May 2024). DOH-designated Center of Excellence in Hematopoietic Stem Cell Transplantation. Manufactured UAE's first CAR-T cells in September 2023 and delivered 26 CAR-T treatments with 80% survival rates. Partnerships with Khalifa University, NYU Abu Dhabi, and AstraZeneca for clinical research.
Stem Cell Therapy Quality in United Arab Emirates: FACT accreditation (April 2024), AABB accreditation (March 2025), JCI Gold Seal of Approval (May 2024), DoH Center of Excellence designation, GMP-certified laboratories. Developed virus-free, clinical-grade iPSCs using proprietary protocol (January 2025). Conducted SENTAD-COVID Phase I/II trial with 139 patients. Active clinical trials: OPERA (Type 1 Diabetes), PHOMS (Multiple Sclerosis), TIL observational study (with Cleveland Clinic Abu Dhabi). Collaborates with Kyoto University, University of Cambridge, University of Milano-Bicocca. Led by Professor Yendry Ventura (CEO).
Stem Cell Transplant Quality in United Arab Emirates: FACT accreditation April 2024, JCI Gold Seal May 2024, AABB accreditation 2025, Department of Health Abu Dhabi Centre of Excellence March 2023. 120+ bone marrow transplants and 15 CAR-T therapies through 2024. 13 dedicated positive-pressure inpatient rooms with HEPA filtration. GMP laboratory with 200 CAR-T annual manufacturing capacity. First CAR-T manufacturing in UAE and Middle East. Introduced CASGEVY gene therapy 2025. International patient services. Contact: +971 800 140.